Summit Therapeutics Inc. (SMMT) has a market capitalization of $15.52B and trades at $20.85. The 52-week range is 13.83-36.91.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -14.5, Earnings Per Share (EPS) of $-1.44.
The stock has a beta of -1.37, operates in the Healthcare sector.
